Skip to main content
padlock icon - secure page this page is secure

Open Access Realizing the Potential of Health-Promoting Rosehips from Dogroses (Rosa sect. Caninae)

Download Article:
(PDF 2,140.7 kb)
Systematics and Genetics: Medicinal effects of rosehips are attributed mainly to dogroses, i.e. species in Rosa sect. Caninae. These are mostly pentaploid and have a unique meiosis with asymmetrical chromosome distribution. Offspring in reciprocal crosses differ widely since seedlings resemble the seed parent more than the pollen parent.

Chemical Contents: Flesh (shells) of rosehips from dogroses contain high levels of antioxidants, mainly polyphenols and ascorbic acid, as well as carotenoids and vitamins B and E. The seeds are rich in polyunsaturated fatty acids and are used for skin treatment and cosmetics. Both shells and seeds, separately or together, are used for health-promoting food and food additives.

Medicinal Effects: The most well-documented studies concern the positive effects on inflammatory processes, especially in patients suffering from osteoarthritis. The exact medicinal role of different rosehip compounds have not been investigated in detail, and the relative importance of fruit flesh versus seed is also not yet determined.

Plant Production and Breeding: Rosehips are mainly harvested by hand from wild or naturalized dogrose bushes. Once the key compounds have been identified, commercial output of rosehips with predictable quality would be facilitated by careful optimization of plant material, cultivation conditions, and post-harvest and processing procedures. Some cultivars have been bred in Europe but breeding goals have not been clearly defined and commercial production is limited. Modern genomic tools have improved breeding programs in many crops but polyploidy and the canina meiosis present considerable challenges for research and breeding in dogroses.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: Antioxidant; functional food; medicinal plant; phytotherapy; plant breeding; plant taxonomy

Document Type: Research Article

Publication date: March 1, 2017

More about this publication?
  • The journal aims to provide updates to researchers about new bioactive compounds with proven activities in various biological screenings and pharmacological models. The journal will contain information about the structures, biological activities and sources of chemical entities discovered or designed by researchers and published in leading journals. The aim is to provide a valuable information source of bioactive compounds synthesized or isolated, which can be used for further development of pharmaceuticals by industry and academia.

    The journal should prove to be essential reading for pharmacologists, pharmaceutical chemists and medicinal chemists who wish to be kept informed and up-to-date with the latest and most important developments about new bioactive compounds of natural or synthetic origin, including recent patents.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more